Miller A, Joyce B, Bartelt K, Deckert J
Baz formlar gnlk, baz formlar ise haftalk kullanlabilir
Meta-analysis has also demonstrated that premixed insulin is more effective at lowering PPG, but less effective at reducing FPG and more often associated with minor hypoglycemia and weight gain than long-acting insulin or oral agents
Yes, semaglutide remains effective for type 2 diabetes, obesity, and related health conditions
Ozempic injection dosage adjustments might be required
The FDA has approved subcutaneous liraglutide (1.8 mg once daily), semaglutide (up to 2.0 mg once weekly) and dulaglutide (up to 4.5 mg once weekly) for the risk of reduction of MACEs in patients with T2DM with established CVD or subcutaneous dulaglutide (up to 4.5 mg once weekly) in patients with multiple CV risk factors